Bispecific Antibody Therapeutics Market Analysis and Size
In 2018, approximately 4,285,033 new cancer cases were detected in China, according to Globocan's estimations. As a result, the increased global prevalence of cancer necessitates new therapeutic choices, driving up demand for bispecific antibodies.
Bispecific antibodies (BsAbs)...
English
Arabic
Français
Español
Português
Türkçe
Dutch
Italiano
Russian
Romaian